FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoeri Schrooten

Research Profile

Living Beings

HIV-1

Physiology

Disorders

HIV Infections

Chemicals & Drugs

Procedures

Geographic Areas

Belgium

Concepts & Ideas

Treatment Failure

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
Vivian Kourí; Daniel Pérez; Jorge Pérez; Lissette Pérez; Yoeri Schrooten; Yudira Soto; Anne-Mieke Vandamme; Lore Vinken; Alina Álvarez; Delmis Álvarez; Yoan Alemán; Carlos Aragonés; Gertjan Beheydt; Jorge Campos; Consuelo Correa; Nathalie Dekeersmaeker; Carlos Fonseca; Stijn Imbrechts; Kristel Van Laethem
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba.
Kris Covens; Nathalie Dekeersmaeker; Yoeri Schrooten; Jan Weber; Dominique Schols; Miguel E Quiñones-Mateu; Anne-Mieke Vandamme; Kristel Van Laethem
Novel recombinant virus assay for measuring susceptibility of human immunodeficiency virus type 1 group M subtypes to clinically approved drugs.
Kris Covens; Kabamba Kabeya; Yoeri Schrooten; Nathalie Dekeersmaeker; Eric Van Wijngaerden; Anne-Mieke Vandamme; Stéphane De Wit; Kristel Van Laethem
Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoeri Schrooten (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Vivian Kourí; Daniel Pérez; Jorge Pérez; Lissette Pérez; Yoeri Schrooten; Yudira Soto; Anne-Mieke Vandamme; Lore Vinken; Alina Álvarez; Delmis Álvarez; Yoan Alemán; Carlos Aragonés; Gertjan Beheydt; Jorge Campos; Consuelo Correa; Nathalie Dekeersmaeker; Carlos Fonseca; Stijn Imbrechts; Kristel Van Laethem
High frequency of antiviral drug resistance and non-B subtypes in HIV-1 patients failing antiviral therapy in Cuba.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2012;55(4):348-55.
2009: Kris Covens; Nathalie Dekeersmaeker; Yoeri Schrooten; Jan Weber; Dominique Schols; Miguel E Quiñones-Mateu; Anne-Mieke Vandamme; Kristel Van Laethem
Novel recombinant virus assay for measuring susceptibility of human immunodeficiency virus type 1 group M subtypes to clinically approved drugs.
Journal of clinical microbiology 2009;47(7):2232-42.
2009: Kris Covens; Kabamba Kabeya; Yoeri Schrooten; Nathalie Dekeersmaeker; Eric Van Wijngaerden; Anne-Mieke Vandamme; Stéphane De Wit; Kristel Van Laethem
Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2009;44(4):325-8.
2008: Kristel Van Laethem; Yoeri Schrooten; Kris Covens; Nathalie Dekeersmaeker; Paul De Munter; Eric Van Wijngaerden; Marc Van Ranst; Anne-Mieke Vandamme
A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes.
Journal of virological methods 2008;153(2):176-81.
2007: Kristel Van Laethem; Paul De Munter; Yoeri Schrooten; Rene Verbesselt; Marc Van Ranst; Eric Van Wijngaerden; Anne-Mieke Vandamme
No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2007;39(1):43-7.
2006: Kristel Van Laethem; Yoeri Schrooten; Sarah Dedecker; Lies Van Heeswijck; Koen Deforche; Eric Van Wijngaerden; Marc Van Ranst; Anne-Mieke Vandamme
A genotypic assay for the amplification and sequencing of gag and protease from diverse human immunodeficiency virus type 1 group M subtypes.
Journal of virological methods 2006;132(1-2):181-6.
2005: Philippe Lemey; Sonia Van Dooren; Kristel Van Laethem; Yoeri Schrooten; Inge Derdelinckx; Patrick Goubau; Françoise Brun-Vézinet; Dolores Vaira; Anne-Mieke Vandamme
Molecular testing of multiple HIV-1 transmissions in a criminal case.
AIDS (London, England) 2005;19(15):1649-58.
2005: Joke Snoeck; C Riva; K Steegen; Yoeri Schrooten; Bart Maes; Laurence Vergne; Kristel Van Laethem; Martine Peeters; Anne-Mieke Vandamme
Optimization of a genotypic assay applicable to all human immunodeficiency virus type 1 protease and reverse transcriptase subtypes.
Journal of virological methods 2005;128(1-2):47-53.
2005: Kristel Van Laethem; Yoeri Schrooten; Philippe Lemey; Eric Van Wijngaerden; Stéphane De Wit; Marc Van Ranst; Anne-Mieke Vandamme
A genotypic resistance assay for the detection of drug resistance in the human immunodeficiency virus type 1 envelope gene.
Journal of virological methods 2005;123(1):25-34.
2004: Inge Derdelinckx; Kristel Van Laethem; Bart Maes; Yoeri Schrooten; Stéphane De Wit; Eric Florence; Katrien Fransen; Sergio García Ribas; Denise Marissens; Michel Moutschen; Dolores Vaira; Georges Zissis; Marc Van Ranst; Eric Van Wijngaerden; Anne-Mieke Vandamme
Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response.
Journal of acquired immune deficiency syndromes (1999) 2004;37(5):1664-6.
2004: Bart Maes; Yoeri Schrooten; Joke Snoeck; Inge Derdelinckx; Marc Van Ranst; Anne-Mieke Vandamme; Kristel Van Laethem
Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory.
Journal of virological methods 2004;119(1):45-9.
2004: Joke Snoeck; Kristel Van Laethem; Philippe Hermans; Eric Van Wijngaerden; Inge Derdelinckx; Yoeri Schrooten; David A M C van de Vijver; Stéphane De Wit; Nathan Clumeck; Anne-Mieke Vandamme
Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001.
Journal of acquired immune deficiency syndromes (1999) 2004;35(3):279-85.
2003: Inge Derdelinckx; Kristel Van Laethem; Bart Maes; Yoeri Schrooten; Kirsten De Schouwer; Stéphane De Wit; Katrien Fransen; Sergio García Ribas; Michel Moutschen; Dolores Vaira; Georges Zissis; Marc Van Ranst; Eric Van Wijngaerden; Anne-Mieke Vandamme
Performance of the VERSANT HIV-1 resistance assays (LiPA) for detecting drug resistance in therapy-naive patients infected with different HIV-1 subtypes.
FEMS immunology and medical microbiology 2003;39(2):119-24.
2002: Koen A De Smet; Sabina De Geest; Inge Derdelinckx; Herman Bobbaers; An Carbonez; Ann E Deschamps; Veerle De Graeve; Veerle De Saar; Helga Ceunen; Koen De Smet; Bart Maes; Willy E Peetermans; Yoeri Schrooten; Jan Desmyter; Erik De Clercq; Marc Van Ranst; Eric Van Wijngaerden; Anne-Mieke Vandamme
A combination of poor adherence and a low baseline susceptibility score is highly predictive for HAART failure.
Antiviral chemistry & chemotherapy 2002;13(4):231-40.